Agios Pharmaceuticals AGIO Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 88.3%-0.3pp | 88.6%-0.7pp | 89.3%+1.2pp | 88%— | |
| Operating margin | -873.9%+293pp | -1,166.5%+293pp | -1,459.5%+1,273pp | -2,732.1%— | |
| Net margin | -764%— | —— | -1,312.6%— | —— | |
| EBITDA margin | -864.3%+287pp | -1,151%+284pp | -1,434.8%+1,237pp | -2,671.9%— | |
| Free cash flow margin | -698.3%+374pp | -1,072.7%+34.8pp | -1,107.5%+1,100pp | -2,207.6%— | |
| Returns | |||||
| Return on equity | -30.2%— | —— | -36.8%— | —— | |
| Return on assets | -27.9%— | —— | -32.4%— | —— | |
| Return on invested capital | -35.4%+1.3pp | -36.8%+5.7pp | -42.5%-7.7pp | -34.8%+13.6pp | |
| Efficiency | |||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | |
| Inventory turnover | 0.2×0.0× | 0.2×0.0× | 0.2×— | —— | |
| Liquidity | |||||
| Current ratio | 11.5×-0.4× | 11.9×-0.4× | 12.3×-1.0× | 13.3×-4.5× | |
| Quick ratio | 11.1×-0.5× | 11.6×-0.4× | 12×-1.2× | 13.2×-4.6× | |
| Cash ratio | 1.1×+0.1× | 0.9×-0.4× | 1.3×-0.9× | 2.2×-1.2× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×-0.1× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -8.4×+0.5× | -8.9×+2.9× | -11.7×— | —— | |
| Per Share | |||||
| Book value per share | $20.58-22.7% | $26.62+82.7% | $14.57-27.5% | $20.09-6.0% | |
| Valuation | |||||
| Market capitalization | $1.59B-15.3% | $1.87B+50.6% | $1.24B-19.3% | $1.54B-13.6% | |
| Enterprise value | $1.54B-17.1% | $1.85B+51.0% | $1.23B-17.5% | $1.49B-11.3% | |
| Price / sales | 29.4×-22.0× | 51.3×+4.9× | 46.4×-61.9× | 108.3×— | |
| Price / book | 1.3×+0.1× | 1.2×-0.3× | 1.5×+0.1× | 1.4×0.0× | |
| EV / sales | 28.5×-22.3× | 50.8×+5.0× | 45.8×-58.8× | 104.6×— | |
| Free cash flow yield | -23.8%-2.9pp | -20.9%+3.0pp | -23.9%-3.5pp | -20.4%+2.8pp | |
| Earnings yield | -26%— | —— | -28.3%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Agios Pharmaceuticals's profit margins?
- Agios Pharmaceuticals (AGIO) runs a 90.0% gross margin and a -720.0% operating margin, with a -639.8% net margin.
- Where do Agios Pharmaceuticals's ratios come from?
- Every ratio is computed from Agios Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.